Searched for
OLMESARTAN MEDOXOMIL
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Macleods Pharmaceuticals recalls products in US for manufacturing issuesThe company had produced the affected lot at its Baddi plant and later marketed in the US market by Macleods Pharma USA Inc.
- Lupin launches generic hypertension drug in US marketThe Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment o...
- Glenmark gets US FDA nod for high blood pressure medicineGlenmark’s current portfolio consists of 119 products authorized for distribution in the US and 66 Abbreviated New Drug Approvals (ANDAs) p...
- Jubilant gets USFDA nod for generic hypertension drugThe company's product is a generic version of Daiichi Sankyo's Azor which is used for the treatment of hypertension.
- Stock pick of the week: What makes Alembic Pharma a good bet in muted pharma industryInvestment in R&D and new facilities focus on exports, new launches and likely growth in revenue of about 35% in the coming years has made ...
- ETMarkets After Hours: RIL among 150 stocks @52-wk high; Axis Bank rallies 3%All the sectoral indices closed in the green on BSE on Tuesday with the BSE Telecom index gaining 2.62 per cent.
- Jubilant Life gets USFDA nod for hypertension drugIn a BSE filing, the company said it has received abbreviated new drug application (ANDA) final approval for olmesartan medoxomil tablets -...
- Alembic Pharma gets USFDA nod for anti-hypertension drugsThe approved products are therapeutically equivalent to the reference listed drug products Benicar and Benicar HCT of Daiichi Sankyo, which...
- Ajanta Pharma launches BP lowering tablets in USAjanta Pharma's Amlodipine + Olmesartan Medoxomil tablets are a generic version of Daiichi Sankyo Inc's Azor tablets
- Glenmark gets USFDA final nod for anti-fungal ointmentGlenmark Pharmaceuticals Inc has been granted final approval by the US Food and Drug Administration (USFDA) for nystatin and triamcinolone ...
- Ranbaxy Laboratories to market Daiichi Sankyo's Sevikarin in RomaniaRanbaxy Labs will market Daiichi Sankyo's antihypertensive drug Sevikarin in Romania expanding its hybrid model strategy to the European co...
- Ranbaxy, Daiichi Sankyo to expand business in MexicoThe two cos will launch Daiichi Sankyo's Olmesartan Medoxomil, used to treat high blood pressure, in Mexico before end of 2011.
- Ranbaxy launches Daiichi Sankyo's heart disease drug in IndiaRanbaxy Laboratories today launched a generic version of Prasugrel, used in treating heart diseases.
- Stocks to watch: Kingfisher Airlines, Ranbaxy, Unitech, SAIL, Patni Computers, BPCLPatni Computers’ net profit for quarter ended December rose to $40.5 million vs $35.7 million and sales grew to $ 170.2 million against $16...
- Ranbaxy to market Daiichi’s products in MexicoDaiichi Sankyo said its Indian arm Ranbaxy Laboratories will start selling its original products in Mexico as part of its strategy to lever...
- Ranbaxy to launch anti-hypertensive drug in AfricaRanbaxy Laboratories will launch parent company Daiichi Sankyo’s anti-hypertensive drug, Olmesartan Medoxomil, in six African countries und...
- Ranbaxy to launch Daiichi's anti-hypertensive drug in IndiaRanbaxy Laboratories will launch in India an anti-hypertensive drug, Olvance -- the first product from its parent Daiichi Sankyo's portfoli...
- Daiichi & Ranbaxy will rank at number 15 globally: Takashi ShodaRanbaxy Laboratories will be the Indian counterpart of Daiichi Sankyo. Whatever we do in India will be done through Ranbaxy.
- Global pharma cos to reduce pill prices in IndiaGlobal pharmaceutical companies are launching their medicines in India at up to one-fifth of their global prices. World News and Trends
Load More
